跳至主要内容
临床试验/NCT01490515
NCT01490515已完成4 期

Embryo Selection Using Non-invasive Metabolomic Analysis Indicates Improvement in Implantation Rates With Fetal Cardiac Activity

Eugonia2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
125
试验地点
2
主要终点
Implantation rates

研究概览

简要总结

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo assessment using non-invasive metabolomic profiling leads to increased implantation rates compared to routine morphology evaluation alone.

详细描述

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The aim of the present study was to determine whether embryo selection using non-invasive metabolomic profiling as an adjunct to morphology leads to increased implantation rates compared to routine morphology evaluation alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with at least 4 fertilized oocytes

排除标准

  • patients with less that 4 fertilized oocytes

结局指标

主要结局

Implantation rates

时间窗: 6 weeks of pregnancy

To compare non-invasive metabolomic profiling and the traditional method of morphology assessment for embryo selection in terms of implantation and pregnancy rates in a clinical IVF program.

次要结局

未报告次要终点

研究者

发起方
Eugonia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验